All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
LIBSET 250MG TABLET_1
LIBSET 250MG TABLET_2
LIBSET 250MG TABLET_3
LIBSET 250MG TABLET_1
15% Off

Libset 250mg Tablet

Prescription Required

Salt Composition : Lapatinib

Manufacturer : INTAS PHARMACEUTICALS LTD

Origin of Medicine : India

MRP: ₹5995
Price : ₹5096
You Save : ₹899 (15%)

30 Tablet(s) In A Bottle

PAP Information :    Contact us for latest updates.

Pincode
Delivery By -

Patient Assistance Programs
Know About PAP

Program Overview: INTAS PHARMACEUTICALS LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of the Libset 250mg tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly. 

Contact us for the latest updates on this exclusive offer. 

Eligibility Criteria: To qualify for the Libset Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Lapatinib 250mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Intas can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: INTAS PHARMACEUTICALS LTD, Patient Assistance Program (PAP), is dedicated to helping patients in need of the Libset 250mg tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly. 

Contact us for the latest updates on this exclusive offer. 

Eligibility Criteria: To qualify for the Libset Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Lapatinib 250mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Intas can avail of it without having to purchase the medication from MrMed.

Introduction to Libset 250mg Tablet

Libset 250mg Tablet contains the active ingredient lapatinib. It is indicated to treat advanced breast cancer and it may be used alone or in combination with other medications. It is effective against cells sensitive to hormones and rapidly multiplying cancer cells that produce most of the protein called human epidermal growth receptor -2.

The common side effects that are likely to occur while you are on the treatment with Libset 250mg Tablet are nausea, vomiting, tiredness, weakness, itching, dry skin, loss of appetite, indigestion, constipation, mouth ulcers, stomach pain, difficulty in sleeping, joint or back pain, cough, breathing problems, headache, etc. If you experience severe allergic reactions, skin rashes, heart, liver, and lung problems, report your physician immediately.

Inform your healthcare provider at the first sign of diarrhea or dehydration. Monitor your blood pressure regularly while taking Libset 250mg Tablet. If you have diarrhea while taking this medication, drink plenty of fluids, eat low-fat, high-protein foods, and avoid milk and its products and herbal supplements.


Uses of Libset 250mg Tablet

  • Treats advanced or HER2 Positive metastatic breast cancer.

Therapeutic Effects of Libset 250mg Tablet

Libset 250mg Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and Epidermal growth factor receptors (EGFRs) from signaling, which are produced by breast cancer cells. It kills cancer cells and slows down their growth. 


Interaction of Libset 250mg Tablet with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Libset 250mg Tablet Injection and cause undesirable side effects.


More Information about Libset 250mg Tablet

  • Store below 30°C and away from light.

How to consume Libset 250mg Tablet

Take Libset 250mg Tablet exactly as prescribed by your doctor. Take this medicine at least 1 hour before or after taking the food. Swallow the tablet and do not crush, open, or dissolve them. 


Safety Advices for Libset 250mg Tablet

Image Not Available  

Pregnancy

  

It is not safe to consume Libset 250mg Tablet while you are pregnant. Consult your doctor and use a reliable contraception method to avoid becoming pregnant during this treatment.

Image Not Available  

Breast Feeding

  

Libset 250mg Tablet is unsafe during breastfeeding as this medication tends to pass into the breast milk and affect the baby.

Image Not Available  

Lungs

  

Talk to your doctor if you have any lung conditions before starting treatment with Libset 250mg Tablet.

Image Not Available  

Liver

  

Libset 250mg Tablet should be used with caution in patients with severe liver disease. Consult your physician for advice.

Image Not Available  

Alcohol

  

Avoid drinking alcohol while taking Libset 250mg Tablet as it may cause dizziness.

Image Not Available  

Driving

  

Libset 250mg Tablet may affect your ability to drive or perform activities that require focus. Exercise caution while driving or using machines.


Side Effects of Libset 250mg Tablet

Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them.

Serious

  • Diarrhea
  • Severe allergic reactions
  • Skin rash
  • Heart problems

Common

  • Loss of appetite
  • Nausea, vomiting
  • Tiredness, weakness
  • Indigestion
  • Constipation
  • Sore mouth or mouth ulcers
  • Stomach pain
  • Trouble sleeping
  • Back pain
  • Pain in the hands and feet
  • Joint or back pain
  • Cough, breathlessness
  • Headache
  • Nose bleed
  • Hot flush
  • Unusual hair loss
  • Dry skin and itching

 


Word of Advice

Libset 250mg Tablet can cause severe diarrhea, so it is advised to take plenty of water during the treatment. Eat a well-balanced diet. Avoid consuming grapefruit juice while on treatment with Libset 250mg Tablet as it affects how the medicine works. This medication makes your skin sensitive to the sun and increases the risk of skin rashes. Avoid spending more time in the sunlight, and ensure that you always apply sunscreen with a good SPF before stepping out. Wash your skin with a soap-free cleanser.


FAQs

Q 1. What is Libset 250mg Tablet used for?

Libset 250mg Tablet is used to treat advanced or HER2 Positive metastatic breast cancer.

Q 2. What is the most common side effect of Libset 250mg Tablet?

The most common side effect of Libset 250mg Tablet is Diarrhea. To prevent dehydration, consume lots of liquids, such as water or juice. If it is serious, consult your doctor right away.

Q 3. How does Libset 250mg Tablet work?

Libset 250mg Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and epidermal growth factor receptors (EGFRs) from signaling, which breast cancer cells produce. It kills cancer cells and slows down their growth.

Q 4. Is it safe to take Libset 250mg Tablet while drinking juice?

No. Drinking grapefruit juice while taking Libset 250mg Tablet can cause harmful interaction. Take this medicine with water only.

Q 5. Can a pregnant woman take Libset 250mg Tablet?

No, Libset 250mg Tablet is unsafe during pregnancy as it may harm the unborn baby. Therefore, it is advisable to tell your healthcare provider if you are pregnant or planning to have a baby before taking this medicine.

Q 6. Is Libset 250mg Tablet safe for breastfeeding women?

Libset 250mg Tablet is unsafe during breastfeeding as this medication passes into the breastmilk and affects the baby. It is not to be taken without the doctor's consent.


Fact Box of Libset 250mg Tablet

Molecule name: Lapatinib

Therapeutic class: Antineoplastic agent

Pharmacological class: Tyrosine kinase inhibitor 

Indications: Treats advanced or HER2 Positive metastatic breast cancer.

References

1. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976. 

2. KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.

3. Novartis Europharm Limited, Electronic medicines compendium (emc), [ Revised on March 2022] [ Accessed on 19th August 2022], https://www.medicines.org.uk/emc/files/pil.6292.pdf

4. GlaxoSmithKline, US Food & Drug Administration, [ Accessed on 19th August 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022059s007lbl.pdf


Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.